CYD-1-79

Overview

CYD-1-79 is a selective positive allosteric modulator of 5-HT2C receptor. CYD-1-79 potentiates 5-HT-evoked intracellular calcium release via a topographically distinct allosteric site. CYD-1-79 shows significant inhibition of binding at dopamine D3 receptor, DAT , and α2A/α2B adrenergic receptors. CYD-1-79 modulates 5-HT2C receptor-mediated spontaneous ambulation in rodents and synergizes with a low dose of a 5-HT2C receptor agonist. CYD-1-79 attenuates relapse vulnerability of psychoactive substance in a rodent self-administration model. CYD-1-79 can be used for the research of neurological disease .

Application

Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Neuronal Signaling | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > 5-HT Receptor | Products > Signaling Pathways > Dopamine Receptor | Products > Signaling Pathways > Dopamine Transporter | Products > Signaling Pathways > Adrenergic Receptor | Products > Signaling Pathways > Calcium Channel

Product Information

• Catalog No.: HY-182091
• CAS No.: 2220235-94-7
• Molecular Formula: C20H40N2O3
• Molecular Weight: 356.54
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source